• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYBoard
  • MYInsights
  • Strategy & Consulting
  • Contact Us
Select Page

Myeloma Awareness Month and Acknowledging Early Symptoms of The Disease

by | Mar 14, 2025 | Uncategorized

Source: CureToday articles Dr. Joseph Mikhael discusses the overlooked symptoms of multiple myeloma in honor of Myeloma Awareness Month. Read More

Expert Explains Early Signs, Treatment Advances and Care in Multiple Myeloma

by | Mar 10, 2025 | Uncategorized

Source: CureToday articles Dr. Joseph Mikhael discusses early signs, treatments and supportive care for multiple myeloma in an interview with CURE. Read More

The FDA Grants ODD to OPN-6602 For Relapsed/Refractory Myeloma

by | Feb 18, 2025 | Uncategorized

Source: CureToday articles The FDA has granted orphan drug designation to the oral agent OPN-6602 for the treatment of patients with relapsed or refractory multiple myeloma. Read More

Unexpected Support in Tough Times With Multiple Myeloma

by | Feb 11, 2025 | Uncategorized

Source: CureToday articles Throughout my experience with multiple myeloma, I was humbled by the unexpected support and kindness shown to me. Read More

‘Readily available biomarker’ can predict outcomes in multiple myeloma

by | Jan 23, 2025 | Uncategorized

Peripheral blood absolute lymphocyte count at diagnosis is an effective biomarker that can be used to risk-stratify patients with multiple myeloma, according to retrospective study results.Continued monitoring of absolute lymphocyte count (ALC) during treatment and...

Rising from Ashes: Rediscovering Myself After Multiple Myeloma

by | Jan 22, 2025 | Uncategorized

Source: CureToday articles I rediscovered myself through community, writing, music and cooking after my journey with multiple myeloma. Read More
« Older Entries

Recent Content

  • Myeloma Awareness Month and Acknowledging Early Symptoms of The Disease
  • Daratumumab-based quadruplet versus triplet induction regimens in transplant-eligible newly diagnosed multiple myeloma: a systematic review and meta-analysis
  • Daratumumab-based quadruplet versus triplet induction regimens in transplant-eligible newly diagnosed multiple myeloma: a systematic review and meta-analysis
  • Correction: Multiple myeloma as a challenging multidimensional random process: a data-driven web-based application for treatment selection
  • Genetic Study Sheds Light on Inherited Risk of Multiple Myeloma
  • A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma
  • Expert Explains Early Signs, Treatment Advances and Care in Multiple Myeloma
  • Treatment of Multiple Myeloma in Patients Refractory to Daratumumab/Anti-CD38 Monoclonal Antibodies: A Systematic Review
  • Pharmacists Play an Essential Role in Bispecific Therapy for Multiple Myeloma
  • Implications of lymphocyte kinetics after chimeric antigen receptor T cell therapy for multiple myeloma
  • Facebook
  • X
  • Instagram
©2016-2024 MYELOMA360
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT